TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
22 hedge funds and large institutions have $5.27M invested in Talis Biomedical Corporation Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
3
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$13K
Top Buyers
| 1 |
TSS
1
Two Sigma Securities
New York
|
$23.5K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$18.7K |
| 3 |
3
Renaissance Technologies
New York
|
$26K |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$5.03K |
| 5 |
5
Morgan Stanley
New York
|
$29.7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 10 | +2 | +25% |
|